Printer Friendly

VisionBanker aims to reinvent global eyecare.

BANKING AND CREDIT NEWS-July 11, 2019-VisionBanker aims to reinvent global eyecare


VisionBanker, a startup that aims to help improve the vision of global consumers through technology, has announced that they plan to raise USD 10 million through a token sale, the company said.

The pre sale is currently ongoing, with public sales to be launched in Q4 of 2019.

VisionBanker aims to tap on the growing eyecare market, which is expected to be worth USD 182 billion by 2023 [1], by using technologies such as blockchain, mobile apps and facial recognition to help global consumers get better access to better-fitting eyecare, while incentivising them through a token system (VBK tokens) to do regular eye check-ups.

At the same time, optometric professionals are also incentivised through tokens to provide answers to questions posed by the app's users -- thus creating a decentralised, distributed and public ledger that allows consumers to solve their eyecare needs easily. All these data will be stored on blockchain, and can be used to help governments and organisations with an interest in eye health research and make decisions through actual and anonymised data.

VisionBanker was founded in Q4 2018 by the team behind SpecTruck, led by Dato Seri David Sew. Since 2017, SpecTruck is the first One-Stop Mobile Optical concept stall in Malaysia, serving both local communities in both urban and rural areas to provide badly needed eyecare to the community. For more information, visit

((Comments on this story may be sent to

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Banking & Credit News (BCN)
Date:Jul 11, 2019
Previous Article:Allied Payment Network adds product manager and software engineer.
Next Article:IBERIABANK declares cash dividend on Series C preferred stock.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |